|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing balances due from other banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Available for sale securities at fair value (amortized cost of $400,211 and $392,564, respectively) | ||||||||||||||||||||
| Held to maturity securities at amortized cost (estimated fair value of $42,720 and $42,144, respectively) | ||||||||||||||||||||
| Equity securities | ||||||||||||||||||||
| Equity Securities, Held In Correspondent Banks | ||||||||||||||||||||
| Total equity securities | ||||||||||||||||||||
| Available for sale securities at fair value (amortized cost of $459,375 and $416,002, respectively) | ||||||||||||||||||||
| Held to maturity securities at amortized cost (fair value of $49,450 and $50,540, respectively) | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Less: allowance for credit losses | ||||||||||||||||||||
| Loans, net | ||||||||||||||||||||
| Equity securities at fair value | ||||||||||||||||||||
| Marketable Securities and Mutual Funds | ||||||||||||||||||||
| Equity Securities, Held In Correspondent Banks | ||||||||||||||||||||
| Bank premises and equipment, net of accumulated depreciation of $25,268 and $23,836, respectively | ||||||||||||||||||||
| Other real estate owned, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Goodwill and other intangible assets, net | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Advances from Federal Home Loan Bank | ||||||||||||||||||||
| Borrowings under Bank Term Funding Program | ||||||||||||||||||||
| Repurchase agreements | ||||||||||||||||||||
| Subordinated debt, net of unamortized issuance costs | ||||||||||||||||||||
| Junior subordinated debt | ||||||||||||||||||||
| Accrued taxes and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Preferred stock, no par value per share; 5,000,000 shares authorized; 6.5% Series A Non-Cumulative Perpetual Convertible Preferred Stock; 32,500 shares ($1,000 liquidation preference) issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, $1.00 par value per share; 40,000,000 shares authorized; 13,777,385 and 9,798,948 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
